Compositions for pre-surgical nutritional supplements
US-2024189256-A1 · Jun 13, 2024 · US
US10130652B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10130652-B2 |
| Application number | US-201113699248-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 23, 2011 |
| Priority date | May 24, 2010 |
| Publication date | Nov 20, 2018 |
| Grant date | Nov 20, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to the use as an anti-inflammatory of tamarind seed polysaccharide (TSP) and to anti-inflammatory compositions which contain it as active ingredient. Anti-inflammatory compositions containing TSP are particularly useful for topical administration in the treatment of inflammatory diseases of the skin and mucosa.
Opening claim text (preview).
The invention claimed is: 1. A method of treating inflammatory diseases comprising: administering between 0.2% and 1% (w/w) of Tamarind seed polysaccharide in combination with between 0.2% and 1% (w/w) of an extract of Ferula hermonis in the total composition to a patient in need thereof, wherein said inflammatory diseases comprise dermatitis, mucositis or stomatits. 2. The method of claim 1 for topical administration. 3. An anti-inflammatory pharmaceutical and/or dermocosmetic composition comprising between 0.2% and 1% (w/w) of tamarind seed polysaccharide in combination with between 0.2% and 1% (w/w) of an extract of Ferula hermonis in the total composition as active ingredients mixed with one or more acceptable excipients. 4. A composition according to claim 3 , for topical administration. 5. A composition according to claim 3 , in the form of cream, ointment, gel, lotion, gum, toothpaste, mouthwash or shampoo. 6. A composition according to claim 3 , comprising at least a further active ingredient selected from the group consisting of antimicrobial agents, anti-inflammatory agents, analgesic agents and wound-healing agents. 7. A composition according to claim 3 , further comprising between 0.2% and 1% (w/w) an extract of Aesculus hippocastanum in the total composition. 8. A method of treating a patient having an inflammatory disease comprising administering between 0.2% and 1% (w/w) of Tamarind see polysaccharide in combination with between 0.2% and 1% (w/w) of an extract of Ferula hermonis in the total composition, wherein said inflammatory disease comprises dermatitis, mucositis or stomatitis. 9. An anti-inflammatory pharmaceutical and/or dermocosmetic composition comprising about 0.2% (w/w) tamarind seed polysaccharide in combination with about 0.2% (w/w) of an extract of Ferula hermonis in the total composition as active ingredients mixed with one or more acceptable excipients.
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics · CPC title
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title
Drugs for dermatological disorders · CPC title
Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters · CPC title
Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.